Value of plasma the soluble CD14 subtype in early diagnosis of sepsis patients with acute renal injury

SHEN Wenwen; LIU Qin; HUANG Kai; JIANG Xiaogan; CHEN Shanghua

doi:10.7619/jcmp.20232835

Journal of Clinical Medicine in Practice > 2024 > 28(10): 46-50. > DOI: 10.7619/jcmp.20232835

SHEN Wenwen, LIU Qin, HUANG Kai, JIANG Xiaogan, CHEN Shanghua. Value of plasma the soluble CD14 subtype in early diagnosis of sepsis patients with acute renal injury[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 46-50. DOI: 10.7619/jcmp.20232835

Citation:

PDF (1074 KB)

Value of plasma the soluble CD14 subtype in early diagnosis of sepsis patients with acute renal injury

1.
Department of Critical Care Medicine, Wuhu Hospital Affiliated to East China Normal University, Wuhu, Anhui, 241000
2.
Department of Critical Care Medicine, Yijishan Hospital Affiliated to Wannan Medical College, Wuhu, Anhui, 241000

More Information

Received Date: September 05, 2023
Revised Date: December 03, 2023
Available Online: May 31, 2024

Graphical Abstract

Abstract

Abstract

Objective
To evaluate the diagnostic value of plasma the soluble CD14 subtype (sCD14-ST, renamed as presepsin) in early diagnosis of sepsis patients with acute kidney injury (AKI).
Methods
A total of 110 patients with AKI in intensive care unit(ICU)of Wuhu Hospital Affiliated to East China Normal University from January 2021 to December 2022 were prospectively selected. The patients were divided into AKI stage 1 group (n=34), AKI stage 2 group (n=36) and AKI stage 3 group (n=40) according to the staging criteria defined byKidney Disease: Improving Global Outcomes (KDIGO) in 2012, and 53 non-AKI patients in the same period were selected as the control group. The patients were further divided into non-sepsis group and sepsis group according to whether combined sepsis or not. Plasma Presepsin levels were recorded in all the patients. Receiver operating characteristic (ROC) curve was drawn to evaluate the diagnostic value of Presepsin inearly sepsis in AKI patients, and the optimal cutoff value was found using Jorden index.
Results
The level of Presepsin in the sepsis group was higher than that in non-sepsis group (P < 0.05). In non-sepsis patients, the level of Presepsin increased gradually with the aggravation of renal function injury (P < 0.05). The level of Presepsin in stage 3 AKI group was higher than that in non-AKI group (P < 0.01). ROC curve analysis results showed that thearea under the curve (AUC) of Presepsin level for diagnosing sepsis in stage 1 AKI group, stage 2 AKI group and stage 3 AKI group was smaller than that in non-AKI group (P > 0.05).
Conclusion
Presepsin can be used as a marker for early diagnosis of sepsis in AKI patients, but different thresholds should be used according to the severity of renal impairment.
- Presepsin,
- sepsis,
- acute kidney injury,
- early diagnosis

FullText(HTML)

References (17)

References

[1]	SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. doi: 10.1001/jama.2016.0287
[2]	TAMBO M, TAGUCHI S, NAKAMURA Y, et al. Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis[J]. BMC Urol, 2020, 20(1): 23. doi: 10.1186/s12894-020-00596-4
[3]	KELLUM J A, LAMEIRE N, ASPELIN P, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury[J]. Kidney Int Suppl, 2012, 2(1): 1-138. doi: 10.1038/kisup.2012.1
[4]	RHODES A, EVANS L E, ALHAZZANI W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016[J]. Intensive Care Med, 2017, 43(3): 304-377. doi: 10.1007/s00134-017-4683-6
[5]	潘玉静, 张路霞. 估算肾小球滤过率的评价方法[J]. 中华内科杂志, 2016, 55(3): 237-240.
[6]	MANRIQUE-CABALLERO C L, DEL RIO-PERTUZ G, GOMEZ H. Sepsis-Associated Acute Kidney Injury[J]. Crit Care Clin, 2021, 37(2): 279-301. doi: 10.1016/j.ccc.2020.11.010
[7]	LABRO G, APTEL F, PUYRAVEAU M, et al. Impact on antimicrobial consumption of procalcitonin-guided antibiotic therapy for pneumonia/pneumonitis associated with aspiration in comatose mechanically ventilated patients: a multicenter, randomized controlled study[J]. Ann Intensive Care, 2021, 11(1): 145. doi: 10.1186/s13613-021-00931-4
[8]	DZIARSKI R, TAPPING R I, TOBIAS P S. Binding of bacteri al peptidoglycan to CD14[J]. J Biol Chem, 1998, 273(15): 8680-8690. doi: 10.1074/jbc.273.15.8680
[9]	SHIRAKAWA K, NAITOU K, HIROSE J, et al. The new sepsis marker, sCD14-ST, induction mechanism in the rabbit sepsis models[J]. Crit Care, 2010, 14(Suppl 2): 19. doi: 10.1186/cc9122
[10]	HASSAN E A, ABDEL REHIM A S, AHMED A O, et al. Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ⅲ Patients[J]. Medicina (Kaunas, Lithuania), 2019, 55(2): 1-11.
[11]	KOIZUMI Y, SAKANASHI D, MOHRI T, et al. Can Presepsin uniformly respond to various pathogens- an in vitro assay of new sepsis marker[J]. BMC Immunol, 2020, 21(1): 33. doi: 10.1186/s12865-020-00362-z
[12]	NAKAMURA Y, ISHIKURA H, NISHIDA T, et al. Usefulness of Presepsin in the diagnosis of sepsis in patients with or without acute kidney injury[J]. BMC Anesthesiol, 2014, 14: 88. doi: 10.1186/1471-2253-14-88
[13]	HAN S, KIM M J, KO H J, et al. Diagnostic and Prognostic Roles of C-Reactive Protein, Procalcitonin, and Presepsin in Acute Kidney Injury Patients Initiating Continuous Renal Replacement Therapy[J]. Diagnostics (Basel), 2023, 13(4): 777. doi: 10.3390/diagnostics13040777
[14]	奚希相, 李文放, 马金苗, 等. 尿NGAL联合MEDS评分评估脓毒症合并急性肾损伤患者病情及预后[J]. 第二军医大学学报, 2017, 38(2): 244-248. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201702020.htm
[15]	TAKAHASHI G, SHIBATA S, FUKUI, et al. Diagnostic accuracy of procalcitonin and presepsin for infectious disease in patients with acute kidney injury[J]. Diagn Microbiol Infect Dis, 2016, 86(2): 205-210. doi: 10.1016/j.diagmicrobio.2016.07.015
[16]	NAKAMURA Y, MURAI A, MIZUNUMA M, et al. Potential use of procalcitonin as biomarker for bacterial sepsis in patients with or without acute kidney injury[J]. J Infect Chemother, 2015, 21(4): 257-263. doi: 10.1016/j.jiac.2014.12.001
[17]	NAKAMURA Y, HOSHINO K, KIYOMI F, et al. Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury[J]. Clin Chim Acta, 2019, 490: 200-206. doi: 10.1016/j.cca.2018.09.013

Cited By

Cited by

Periodical cited type(18)

1.	杜菊红，王利英. 以护士为主导的早期活动方案结合积极心理干预对ICU机械通气患者通气状态、获得性衰弱发生率及康复积极性的影响. 临床医学研究与实践. 2023(02): 128-130 .
2.	张春兰，王爱玲，汤茂枝. 基于目标策略的针对性护理在ICU机械通气患者中的应用. 当代护士(中旬刊). 2023(07): 112-115 .
3.	蔡洁玫. 计划性护理干预对重症颅脑损伤患者并发症发生率的影响. 系统医学. 2021(12): 172-175 .
4.	张媛媛，范银红，朱美蓉. 综合ICU呼吸机相关性肺炎患者的护理干预研究. 中国医药科学. 2021(18): 106-109 .
5.	陶佩佩，张兰香，李鑫鑫. 早期渐进性康复训练应用于颅脑损伤机械通气的价值. 安徽卫生职业技术学院学报. 2020(01): 138-139 .
6.	李小燕. 综合性护理干预对内科ICU机械通气患者VAP及治疗效果的影响. 实用临床护理学电子杂志. 2020(05): 51 .
7.	黄晓哪，徐振虎，骆映峰. 综合护理对机械通气脱机成功率的影响. 中国城乡企业卫生. 2020(03): 23-25 .
8.	宋云梅，陈琳，康丽钦，潘希雪，范勲香. 集束化护理配合吸痰器排痰在重型颅脑损伤患者中的应用. 医疗装备. 2020(09): 178-179 .
9.	刘娜. 针对性气道护理对重症颅脑损伤患者排痰效果及VAP发生率的影响. 现代诊断与治疗. 2020(10): 1673-1674 .
10.	刘明月. 预见性护理在重症监护室颅脑损伤术后机械通气患者中的应用效果. 中国民康医学. 2020(19): 157-159 .
11.	陈景顺，王艳娜，陈秀燕. 循证护理对控制机械通气患者呼吸机相关性肺炎的影响. 中国当代医药. 2019(11): 230-232 .
12.	冯世佩. 探讨神经外科颅脑损伤患者机械通气的护理方法. 饮食科学. 2019(08): 283 .
13.	李媚. 综合性护理干预对内科ICU机械通气患者VAP及治疗效果的影响观察. 基层医学论坛. 2019(27): 3885-3886 .
14.	李丽. 机械通气呼吸机相关性肺炎患者感染病原菌特点及护理. 国际护理学杂志. 2019(20): 3409-3413 .
15.	翟健，刘佳，陈明. 综合口腔护理在预防ICU机械通气患者呼吸机相关性肺炎中的效果观察. 当代医学. 2018(09): 157-158 .
16.	刘淑贞，闫小红. 个性化口腔护理在ICU气管插管机械通气中的应用. 河南医学研究. 2018(01): 167-168 .
17.	赵调调，白雷丽. 重症颅脑损伤患者应用针对性气道护理干预对排痰效果及VAP发生率的影响. 临床医学研究与实践. 2018(18): 165-166 .
18.	彭怡青. 振动排痰机在重型颅脑损伤患者呼吸机相关性肺炎预防中的应用价值. 基层医学论坛. 2018(07): 998-999 .

Other cited types(1)

Get Citation

PDF

XML

Article views (146) PDF downloads (3) Cited by(19)

Turn off MathJax

Article Contents

Abstract

References

Value of plasma the soluble CD14 subtype in early diagnosis of sepsis patients with acute renal injury

Abstract

References

Cited by

Periodical cited type(18)

Other cited types(1)

Catalog

Export File

Citation

Format

Content